We propose that Bif-1 regulates the activation of NLRP3 inflammasomes and is also involved in the anti-inflammatory mechanisms of CAN, which may provide new ideas for the treatment of patients with infectious pneumonia, particularly those concurrent with diabetes. Here, NLRP3 is linked to diabetes mellitus.